Cardio Diagnostics Holdings, Inc. (CDIO) NASDAQ

3.42

+0.06(+1.79%)

Updated at December 24 12:55PM

Currency In USD

Cardio Diagnostics Holdings, Inc.

Address

400 N Aberdeen St

Chicago, IL 60642

United States of America

Phone

855 226 9991

Sector

Healthcare

Industry

Biotechnology

Employees

13

First IPO Date

January 14, 2022

Key Executives

NameTitlePayYear Born
Meeshanthini DoganCo-Founder, Chief Executive Officer & Director311,0001989
Timur DoganChief Technology Officer259,1671989
Elisa Michael LuqmanChief Financial Officer & Principal Accounting Officer275,0001964
Robert A. PhilibertCo-Founder, Chief Medical Officer & Director01962

Description

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.